FDA Commissioner Search Turns To Alternates: Ex-Merck Exec Added To List
One of the alternate FDA commissioner candidates under consideration by the Bush Administration is geneticist and former Merck R&D exec Thomas Caskey, MD.
You may also be interested in...
GlaxoSmithKline is initiating direct-to-consumer advertising to support Paxil for generalized anxiety disorder to coincide with the market entrance of the first generic versions of Prozac.
Pharmacia's Celebrex is showing a growth curve that is typical for products in the non-steroidal anti-inflammatory class, CEO Fred Hassan acknowledged during a July 25 analysts call.
Medicare drug program premiums could be lowered through joint federal/state funding of subsidies for low-income beneficiaries, Sen. Graham (D-Fla.) told a press briefing July 18.